483
GlaxoSmithKline Biologicals SAGlaxoSmithKline Biologicals SA – FDA 483, Jun 24, 2019
Record Details
GlaxoSmithKline Biologicals SA, a vaccine manufacturer in Rixensart, Belgium, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate laboratory controls, insufficient investigation into Water for Injection contamination, deficient corrective actions, and poor equipment maintenance. These issues indicate a need for improved quality systems and adherence to manufacturing standards.
View Company Profile
ID · 2460b5ec-845d-4add-905f-e53591d5c1f2
Other documents for GlaxoSmithKline Biologicals SA
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.